German Medical Device Company Settles Allegations of Pervasive Global Bribery With SEC and DOJ

Fresenius Medical Care AG & Co. KGaA, a leading provider of products and services for people with chronic kidney failure based in Bad Homburg, Germany, recently settled allegations with both the SEC and DOJ that it engaged in bribery in myriad ways in myriad countries. We analyze how, despite its self-report, the company did not receive full cooperation credit and is required to retain a compliance monitor for two years. Fresenius will also pay more than $200 million in disgorgement and penalties.

To read the full article

Continue reading your article with an ACR subscription.